| abstract |
The invention relates to an agent used for producing a medicament for treating dementia disorders, in which a treatment of this illness that is more effective than classical therapy is achieved by an active ingredient combination consisting of a substance, which increases the dopamine concentration in the synaptic gap of the nerve cells of the brain, with a local anesthetic agent of the anilide group. |